Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
University of Florida
Institut du Cancer de Montpellier - Val d'Aurelle
Guerbet
Mayo Clinic
Tanabe Pharma America, Inc.
BioXcel Therapeutics Inc
Jonsson Comprehensive Cancer Center
University of Utah
RECORDATI GROUP
Charite University, Berlin, Germany
Merck Sharp & Dohme LLC